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relation to their position within the stent and their morphology (color-
coded, Figure).CONCLUSIONS (1) This novel 3D OCT plaque analysis is feasible, and
allows comprehensive evaluation and quantiﬁcation of intracoronary
plaques and their spatial relationship with adjacent structures (e.g.
stent struts, side branches, thrombi). (2) Coronary stent placement did
not stop atherosclerotic plaque progression in this small patient
group.
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BACKGROUND Intravascular Ultrasound (IVUS)-derived plaque
burden (PB) is a powerful predictor of major adverse cardiovascular
events (MACE). While OCT provides histology-grade deﬁnition of
coronary plaque morphology in vivo, it does not allow for direct
assessment of PB due to limited depth penetration. The value of OCT
for the estimation of plaque burden has not been investigated.
Accordingly, we sought to identify OCT-derived correlates of IVUS PB
and to assess the diagnostic accuracy of OCT in detecting lesions with
large plaque burden (PB 70%).
METHODS We retrospectively analyzed a total of 110 consecutive
patients with stable coronary disease who underwent optical coher-
ence tomography (OCT), IVUS, and near infrared spectroscopy (NIRS)
before their percutaneous coronary intervention (PCI). Culprit lesions
were divided according to IVUS-derived PB 70% (PB Large; n¼86)
and lesions with PB<70% (PB small; n¼24).RESULTS Simultaneous OCT analysis showed increased maximum
lipid arcs (220.100 vs. 118.450, P < 0.01), longer lipid pools (8.00 mm
vs. 2.00 mm, P < 0.032); greater lipid volume index [averaged lipid
arc  lipid length] (991.79 vs. 179.57, P < 0.002), thinner ﬁbrous caps
(80.00 mm vs. 110.00 mm, P < 0.009), smaller minimum lumen cross
sectional area (1.62 mm2 vs. 2.13 mm2, P¼0.002), and a higher lumen
area stenosis (72% vs. 60%, P¼0.001). Lipid volume index, lipid
length, minimum cap thickness, and maximum lipid arc in combina-
tion with lumen area stenosis had signiﬁcant strong association with
IVUS plaque burden by multivariate linear regression analysis
(R2¼0.445, 0.432, 0.393, 0.336 correspondingly). Best accuracy for the
detection of PB Large was achieved using maximum lipid arc ¼ 144.60
(area under the curve (AUC) ¼ 0.806; SS¼84%, SP¼75%), and lumen
area stenosis ¼ 69.2% (AUC ¼ 0.764; SS¼66%, SP¼83%) as cutoff
values.
CONCLUSIONS OCT characteristics of the lipid core size (maximum
arc, length, lipid volume index) and lumen area stenosis provide the
strongest correlation with IVUS plaque burden.
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